VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Status unconfirmed · Phase 1
Conditions studied: Mitral Valve Regurgitation, Left Ventricular Dysfunction, Heart Failure, Mitral Insufficiency, Mitral Incompetence, Ischemic Heart Disease
In brief
The purpose of this prospective, non-randomized, single-arm feasibility study is to evaluate safety and feasibility of the iCoapsys System in patients with functional mitral valve insufficiency caused by annular dilation and/or papillary muscle displacement.
Key facts
- Study ID
- NCT00512005
- Run by
- Myocor
- People needed
- 30
- Starts
- 2008-01-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2009-06-24
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Emory University Hospital — Atlanta, Georgia, United States (enrolling)
- Evanston Northwestern Healthcare - Evanston Hospital — Evanston, Illinois, United States (enrolling)
- Shawnee Mission Hospital — Shawnee Mission, Kansas, United States (enrolling)
- Abbott Northwestern Hospital — Minneapolis, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.